LWM
AGN

LBA Wealth Management’s Allergan plc AGN Stock Holding History

LBA Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$142K Buy
596
+475
+393% +$111K 0.07% 120
2016
Q4 		$25K Sell
121
-4,152
-97% -$860K 0.01% 246
2016
Q3 		$984K Sell
4,273
-15
-0.3% -$3.67K 0.56% 32
2016
Q2 		$991K Sell
4,288
-265
-6% -$61.1K 0.56% 33
2016
Q1 		$1.22M Sell
4,553
-400
-8% -$115K 0.71% 27
2015
Q4 		$1.55M Sell
4,953
-144
-3% -$42.9K 0.89% 18
2015
Q3 		$1.39M Buy
5,097
+253
+5% +$77.7K 0.87% 19
2015
Q2 		$1.47M Sell
4,844
-60
-1% -$17.9K 0.92% 20
2015
Q1 		$1.46M Buy
4,904
+504
+11% +$144K 0.92% 19
2014
Q4 		$1.13M Sell
4,400
-420
-9% -$105K 0.75% 26
2014
Q3 		$1.16M Buy
4,820
+50
+1% +$11.2K 0.81% 25
2014
Q2 		$1.06M Buy
4,770
+10
+0.2% +$2.07K 0.87% 29
2014
Q1 		$980K Sell
4,760
-25
-0.5% -$4.95K 0.8% 30
2013
Q4 		$804K Buy
+4,785
New +$748K 0.66% 41

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LBA Wealth Management's AGN Position: Q1 2017 in Review

LBA Wealth Management increased its Allergan plc (AGN) stake by 393% in Q1 2017, buying an estimated $111K and bringing the position to 596 shares worth $142K. The position accounts for 0.07% of the portfolio, ranked #120.

LBA Wealth Management first reported a position in AGN in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.55M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • LBA Wealth Management held 596 shares of Allergan plc worth $142K as of Q1 2017.
  • LBA Wealth Management bought 475 Allergan plc shares in Q1 2017, an estimated $111K.
  • Allergan plc made up 0.07% of LBA Wealth Management's portfolio in Q1 2017, its #120 holding.
  • LBA Wealth Management first reported a position in Allergan plc in Q4 2013 and has held it in 14 quarters since.
  • LBA Wealth Management's Allergan plc position peaked at $1.55M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.